210 related articles for article (PubMed ID: 19903138)
1. Iron oxide based MR contrast agents: from chemistry to cell labeling.
Laurent S; Boutry S; Mahieu I; Vander Elst L; Muller RN
Curr Med Chem; 2009; 16(35):4712-27. PubMed ID: 19903138
[TBL] [Abstract][Full Text] [Related]
2. Magnetic iron oxide nanoparticles for biomedical applications.
Laurent S; Bridot JL; Elst LV; Muller RN
Future Med Chem; 2010 Mar; 2(3):427-49. PubMed ID: 21426176
[TBL] [Abstract][Full Text] [Related]
3. Biological properties of iron oxide nanoparticles for cellular and molecular magnetic resonance imaging.
Schlorf T; Meincke M; Kossel E; Glüer CC; Jansen O; Mentlein R
Int J Mol Sci; 2010 Dec; 12(1):12-23. PubMed ID: 21339973
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
Gupta AK; Gupta M
Biomaterials; 2005 Jun; 26(18):3995-4021. PubMed ID: 15626447
[TBL] [Abstract][Full Text] [Related]
5. Towards MRI microarrays.
Hall A; Mundell VJ; Blanco-Andujar C; Bencsik M; McHale G; Newton MI; Cave GW
Chem Commun (Camb); 2010 Apr; 46(14):2420-2. PubMed ID: 20379545
[TBL] [Abstract][Full Text] [Related]
6. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.
Wang YX; Hussain SM; Krestin GP
Eur Radiol; 2001; 11(11):2319-31. PubMed ID: 11702180
[TBL] [Abstract][Full Text] [Related]
7. Stabilization and functionalization of iron oxide nanoparticles for biomedical applications.
Amstad E; Textor M; Reimhult E
Nanoscale; 2011 Jul; 3(7):2819-43. PubMed ID: 21629911
[TBL] [Abstract][Full Text] [Related]
8. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents.
Lee N; Hyeon T
Chem Soc Rev; 2012 Apr; 41(7):2575-89. PubMed ID: 22138852
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic nanosystems based on iron oxide nanoparticles for biomedical imaging.
Liu F; Laurent S; Fattahi H; Vander Elst L; Muller RN
Nanomedicine (Lond); 2011 Apr; 6(3):519-28. PubMed ID: 21542689
[TBL] [Abstract][Full Text] [Related]
10. Comparison of superparamagnetic and ultrasmall superparamagnetic iron oxide cell labeling for tracking green fluorescent protein gene marker with negative and positive contrast magnetic resonance imaging.
Zhang Z; Dharmakumar R; Mascheri N; Fan Z; Wu S; Li D
Mol Imaging; 2009; 8(3):148-55. PubMed ID: 19723472
[TBL] [Abstract][Full Text] [Related]
11. Functionalizable silica-based micron-sized iron oxide particles for cellular magnetic resonance imaging.
Raschzok N; Langer CM; Schmidt C; Lerche KH; Billecke N; Nehls K; Schlüter NB; Leder A; Rohn S; Mogl MT; Lüdemann L; Stelter L; Teichgräber UK; Neuhaus P; Sauer IM
Cell Transplant; 2013; 22(11):1959-70. PubMed ID: 23294541
[TBL] [Abstract][Full Text] [Related]
12. Metallic iron nanoparticles for MRI contrast enhancement and local hyperthermia.
Hadjipanayis CG; Bonder MJ; Balakrishnan S; Wang X; Mao H; Hadjipanayis GC
Small; 2008 Nov; 4(11):1925-9. PubMed ID: 18752211
[No Abstract] [Full Text] [Related]
13. Predictable Heating and Positive MRI Contrast from a Mesoporous Silica-Coated Iron Oxide Nanoparticle.
Hurley KR; Ring HL; Etheridge M; Zhang J; Gao Z; Shao Q; Klein ND; Szlag VM; Chung C; Reineke TM; Garwood M; Bischof JC; Haynes CL
Mol Pharm; 2016 Jul; 13(7):2172-83. PubMed ID: 26991550
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Gold-Coated Iron Oxide Nanoparticles as Negative T2 Contrast Agent in Small Animal MRI Studies.
Iancu SD; Albu C; Chiriac L; Moldovan R; Stefancu A; Moisoiu V; Coman V; Szabo L; Leopold N; Bálint Z
Int J Nanomedicine; 2020; 15():4811-4824. PubMed ID: 32753867
[TBL] [Abstract][Full Text] [Related]
15. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
[TBL] [Abstract][Full Text] [Related]
16. New Perspectives on Biomedical Applications of Iron Oxide Nanoparticles.
Magro M; Baratella D; Bonaiuto E; de A Roger J; Vianello F
Curr Med Chem; 2018 Feb; 25(4):540-555. PubMed ID: 28618993
[TBL] [Abstract][Full Text] [Related]
17. Covalent coupling of gum arabic onto superparamagnetic iron oxide nanoparticles for MRI cell labeling: physicochemical and in vitro characterization.
Palma SI; Carvalho A; Silva J; Martins P; Marciello M; Fernandes AR; del Puerto Morales M; Roque AC
Contrast Media Mol Imaging; 2015; 10(4):320-8. PubMed ID: 25766788
[TBL] [Abstract][Full Text] [Related]
18. On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging.
Adamiano A; Iafisco M; Sandri M; Basini M; Arosio P; Canu T; Sitia G; Esposito A; Iannotti V; Ausanio G; Fragogeorgi E; Rouchota M; Loudos G; Lascialfari A; Tampieri A
Acta Biomater; 2018 Jun; 73():458-469. PubMed ID: 29689381
[TBL] [Abstract][Full Text] [Related]
19. Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling.
Babic M; Horák D; Trchová M; Jendelová P; Glogarová K; Lesný P; Herynek V; Hájek M; Syková E
Bioconjug Chem; 2008 Mar; 19(3):740-50. PubMed ID: 18288791
[TBL] [Abstract][Full Text] [Related]
20. Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T₂ Contrast Agents for MRI.
Martínez-González R; Estelrich J; Busquets MA
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27472319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
